Relationship between DR4 gene promoter methylation and TRAIL resistant in lung adenocarcinomaQI Xiaoyan, WANG Wenwu, SHI Bin, XU Yao, ZHANG Yan, CHEN Xi, OUYANG Xuenong97-103
Influence of nm23-H1 gene transfection on expressions of MMP-9 and TIMP-1 in lung cancer cellsZHENG Haixia, CUI Yongyan, SHEN Donglan, PENG An, HE Yanling104-107
Regulatory effect of miR-155 on the proliferation, apoptosis and expression of breast cancer resistance proteinCHEN Shuru, HUANG Yukang, WU Chucheng, CHEN Di, FANG Qin, PENG Weiqiang108-111
Expression of hedgehog signaling pathway related protein Gli1 in breast cancer and its clinical significanceFENG Fubin, ZHUANG Jing, LIU Ruijuan, WANG Congcong, TANG Shifeng, SUN Changgang112-115
Predictive value of serum CEA for efficacy and prognosis of EGFR mutant advanced lung adenocarcinoma treated with TKIsNONG Jingying, WANG Jinghui, YANG Xinjie, LV Jialin, WU Yuhua, ZHANG Shucai116-121
Prognostic analysis of metastatic non-small cell lung cancer patients treated with helical tomotherapyLI Zhong, LI Jing, LI Zhiqiang, WANG Yan, ZHONG Yu, ZHANG Jinjian, WEN Ting, HOU Youxian, JIA Junsong, CHEN Jing, XU Yanhong122-126
Clinical observation of maintenance therapy with autologous cytokine-induced killer cells in patients with medium and advanced non-small cell lung cancer after first-line treatmentSONG Shuxi, DING Zhenyu, LIU Yongye, YU Huiying, SUN Yinghui, HAN Yaling, MA Dongchu, XIE Xiaodong127-131
Clinicopathological characteristics and prognosis analysis among different molecular subtypes of breast in-vasive ductal carcinomaPANG Qiong, NAN Haocheng, MA Jiequn, ZHAI Haicheng, CHEN Yimeng, QU Shengyang, NAN Kejun, HE Jianjun132-136
The value of combined detection of serum HE4, CA153 in diagnosing breast invasive ductal carcinomaQIN Tian, GONG Zhifeng, QIU Meiting, WU Yongxiao137-139
Analysis of prognostic factors in 210 patients with advanced esophageal carcinoma after chemoradiotherapyPAN Dinglong, LI Jiancheng, YANG Yan, QIU Zidan, CAI Lvjuan, ZHUANG Lizhen140-144
